Position in IQV
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$983,876
-$63,239 QoQ
Shares Held
5,092
-17.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#520
of 1,082 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in IQV Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026SAGESPRING WEALTH PARTNERS, LLC holds $5,885,366 across 9 Diagnostics & Research names. IQV ranks #2 (16.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
3,837 | $1,923,718 | |
| 2 | IQV |
Iqvia Holdings Inc.
This page
|
5,092 | $983,876 | |
| 3 | DHR |
Danaher Corp /De/
|
3,930 | $748,586 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
963 | $506,961 | |
| 5 | A |
Agilent Technologies, Inc.
|
3,444 | $457,466 | |
| 6 | DGX |
Quest Diagnostics Inc
|
1,947 | $412,666 | |
| 7 | WAT |
Waters Corp /De/
|
927 | $347,662 | |
| 8 | ILMN |
Illumina, Inc.
|
1,447 | $254,426 |
All Filings in IQV
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $983,876 | 5,092 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $1,047,115 | 6,140 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,380,410 | 6,124 | Shares | Sole | 2026-01-07 | |
| 2025-09-30 | $1,178,577 | 6,205 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $957,359 | 6,075 | Shares | Sole | 2025-07-28 | |
| 2025-03-31 | $1,033,294 | 5,861 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $912,985 | 4,646 | Shares | Sole | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||